BioCardia, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
BioCardia, Inc. (BCDA) reported Cost of Goods Sold (Deprecated 2018-01-31) of $690.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-03-16
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $165.00K, a 1.79% decline year-over-year.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $147.00K, a 25.00% decline year-over-year.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $203.00K, a 30.13% increase year-over-year.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $175.00K, a 22.57% decline year-over-year.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $690.00K, a 7.51% decline from fiscal 2016.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $746.00K, a 29.69% decline from fiscal 2015.
- BioCardia, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $1.06M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $312.00K derived: sum of 2 quarters · filed 2018-03-16 | $515.00K derived: sum of 3 quarters · filed 2018-03-16 | $690.00K 10-K · filed 2018-03-16 |
| 2017-09-30 | $147.00K 10-Q · filed 2017-11-09 | $350.00K derived: sum of 2 quarters · filed 2017-11-09 | $525.00K 10-Q · filed 2017-11-09 | $693.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | $203.00K 10-Q · filed 2017-08-14 | $378.00K 10-Q · filed 2017-08-14 | $546.00K derived: sum of 3 quarters · filed 2018-03-16 | $742.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | $175.00K 10-Q · filed 2017-05-11 | $343.00K derived: sum of 2 quarters · filed 2018-03-16 | $539.00K derived: sum of 3 quarters · filed 2018-03-16 | $695.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $364.00K derived: sum of 2 quarters · filed 2018-03-16 | $520.00K derived: sum of 3 quarters · filed 2018-03-16 | $746.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | $196.00K 10-Q · filed 2017-11-09 | $352.00K derived: sum of 2 quarters · filed 2017-11-09 | $578.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $156.00K 10-Q · filed 2017-08-14 | $382.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $226.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $1.06M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |